You have 9 free searches left this month | for more free features.

dovitinib

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

Terminated
  • Bladder Cancer
  • Dovitinib
  • Indianapolis, Indiana
  • +2 more
Jul 7, 2022

Solid Tumors Trial in Hospitalet de Llobregat, Fuenlabrada, Madrid (Dovitinib, Dovitinib + Paclitaxel)

Terminated
  • Solid Tumors
  • Dovitinib
  • Dovitinib + Paclitaxel
  • Hospitalet de Llobregat, Barcelona, Spain
  • +2 more
Apr 15, 2020

Gastric Cancer Trial in Seoul (Dovitinib)

Completed
  • Gastric Cancer
  • Dovitinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • dovitinib
  • Seoul,, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020

Solid Tumors, Hepatic Impairment Trial in Worldwide (Dovitinib)

Completed
  • Solid Tumors
  • Hepatic Impairment
  • Dovitinib
  • Los Angeles, California
  • +11 more
Dec 17, 2020

Breast Cancer Trial in Houston (Dovitinib)

Completed
  • Breast Cancer
  • Dovitinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 22, 2019

Prostate Cancer Trial in Houston (Dovitinib, Abiraterone Acetate, Prednisone)

Terminated
  • Prostate Cancer
  • Dovitinib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 26, 2019

Solid Tumors Trial in Worldwide (dovitinib, fulvestrant)

Completed
  • Solid Tumors
  • Las Vegas, Nevada
  • +8 more
Jan 31, 2018

Breast Cancer Trial in Washington (Dovitinib, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Dovitinib
  • Aromatase Inhibitors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 15, 2018

NSCLC, Colorectal Cancer Trial in Sacramento (Dovitinib)

Completed
  • Non-Small Cell Lung Cancer
  • Colorectal Cancer
  • Dovitinib
  • Sacramento, California
    University of California Comprehensive Cancer Center
Jan 5, 2018

Adrenocortical Carcinoma Trial in Spain (Dovitinib)

Completed
  • Adrenocortical Carcinoma
  • Dovitinib
  • Santiago de Compostela, A Coruña, Spain
  • +6 more
Apr 24, 2017

Von Hippel-Lindau Syndrome Trial in Houston (Dovitinib)

Terminated
  • Von Hippel-Lindau Syndrome
  • Dovitinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 21, 2016

Colorectal Cancer, Pancreas Cancer Trial in Washington (Dovitinib)

Terminated
  • Colorectal Cancer
  • Pancreas Cancer
  • Dovitinib
  • Washington, District of Columbia
    Georgetown University- Lombardi Cancer Center
Jun 7, 2016

First or Second Recurrence of Glioblastoma Trial in Bonn (Dovitinib)

Unknown status
  • First or Second Recurrence of Glioblastoma
  • Dovitinib
  • Bonn, Germany
    Department of Neurology and Center of Integrated Oncology, Unive
Apr 18, 2016

Metastatic Breast Cancer Trial in Worldwide (Dovitinib, Fulvestrant, Dovitinib Placebo)

Terminated
  • Metastatic Breast Cancer
  • Dovitinib
  • +2 more
  • Chandler, Arizona
  • +66 more
May 26, 2016

Advanced Malignant Pleural Mesothelioma, MPM Trial in Canada (Dovitinib)

Terminated
  • Advanced Malignant Pleural Mesothelioma
  • MPM
  • Dovitinib
  • Calgary, Alberta, Canada
  • +4 more
Sep 16, 2015

Hepatocellular Carcinoma Trial in Worldwide (dovitinib, sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
  • +23 more
Nov 2, 2015

Metastatic Renal Cell Carcinoma Trial in Worldwide (Dovitinib, Sorafenib)

Completed
  • Metastatic Renal Cell Carcinoma
  • Fayetteville, Arkansas
  • +198 more
Nov 5, 2015

Clear Cell Renal Cell Carcinoma Trial in Auckland (Dovitinib)

Unknown status
  • Clear Cell Renal Cell Carcinoma
  • Dovitinib
  • Auckland, New Zealand
    Auckland Hospital
Feb 1, 2015

Prostate Cancer Trial in Las Vegas (Standard ADT, Dovitinib)

Withdrawn
  • Prostate Cancer
  • Standard ADT
  • Dovitinib
  • Las Vegas, Nevada
    Comprehensive Cancer Centers of Nevada
Jan 15, 2015

Thyroid Cancer Trial in Seoul (Dovitinib)

Completed
  • Thyroid Cancer
  • Dovitinib
  • Seoul, Korea, Republic of
    Division of Medical Oncology, Yonsei Cancer Center, Yonsei Unive
Nov 26, 2014

Metastatic Clear Cell Renal Cancer Trial in London (Dovitinib, Everolimus)

Completed
  • Metastatic Clear Cell Renal Cancer
  • London, United Kingdom
    Barts Health NHS Trust
Nov 11, 2013

Squamous NSCLC Trial in Seoul (Dovitinib)

Unknown status
  • Squamous NSCLC
  • Dovitinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 22, 2013

Multiple Myeloma Trial (Dovitinib, Bortezomib, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Dovitinib
  • +2 more
  • (no location specified)
Feb 18, 2013